
[ Wed, Jun 16th 2021 ]: WOPRAI
[ Wed, Jun 16th 2021 ]: WOPRAI
[ Wed, Jun 16th 2021 ]: WOPRAI
[ Wed, Jun 16th 2021 ]: WOPRAI
[ Wed, Jun 16th 2021 ]: WOPRAI
[ Wed, Jun 16th 2021 ]: WOPRAI
[ Wed, Jun 16th 2021 ]: WOPRAI
[ Wed, Jun 16th 2021 ]: WOPRAI
[ Wed, Jun 16th 2021 ]: WOPRAI
[ Wed, Jun 16th 2021 ]: WOPRAI
[ Wed, Jun 16th 2021 ]: WOPRAI
[ Wed, Jun 16th 2021 ]: WOPRAI
[ Wed, Jun 16th 2021 ]: WOPRAI
[ Wed, Jun 16th 2021 ]: WOPRAI
[ Wed, Jun 16th 2021 ]: WOPRAI
[ Wed, Jun 16th 2021 ]: WOPRAI

[ Tue, Jun 15th 2021 ]: WOPRAI
[ Tue, Jun 15th 2021 ]: WOPRAI
[ Tue, Jun 15th 2021 ]: WOPRAI
[ Tue, Jun 15th 2021 ]: WOPRAI
[ Tue, Jun 15th 2021 ]: WOPRAI
[ Tue, Jun 15th 2021 ]: WOPRAI
[ Tue, Jun 15th 2021 ]: WOPRAI
[ Tue, Jun 15th 2021 ]: WOPRAI
[ Tue, Jun 15th 2021 ]: WOPRAI
[ Tue, Jun 15th 2021 ]: WOPRAI
[ Tue, Jun 15th 2021 ]: WOPRAI
[ Tue, Jun 15th 2021 ]: WOPRAI
[ Tue, Jun 15th 2021 ]: WOPRAI
[ Tue, Jun 15th 2021 ]: WOPRAI
[ Tue, Jun 15th 2021 ]: WOPRAI
[ Tue, Jun 15th 2021 ]: WOPRAI

[ Mon, Jun 14th 2021 ]: WOPRAI
[ Mon, Jun 14th 2021 ]: WOPRAI
[ Mon, Jun 14th 2021 ]: WOPRAI
[ Mon, Jun 14th 2021 ]: WOPRAI
[ Mon, Jun 14th 2021 ]: WOPRAI
[ Mon, Jun 14th 2021 ]: WOPRAI
[ Mon, Jun 14th 2021 ]: WOPRAI
[ Mon, Jun 14th 2021 ]: WOPRAI
[ Mon, Jun 14th 2021 ]: WOPRAI
[ Mon, Jun 14th 2021 ]: WOPRAI
[ Mon, Jun 14th 2021 ]: WOPRAI
[ Mon, Jun 14th 2021 ]: WOPRAI
[ Mon, Jun 14th 2021 ]: WOPRAI
[ Mon, Jun 14th 2021 ]: WOPRAI
[ Mon, Jun 14th 2021 ]: WOPRAI
[ Mon, Jun 14th 2021 ]: WOPRAI
Yun Zhong Initiated (SRPT) at Strong Buy and Held Target at $110 on, Jun 15th, 2021


🞛 This publication is a summary or evaluation of another publication
Yun Zhong of BTIG, Initiated "Sarepta Therapeutics, Inc." (SRPT) at Strong Buy and Held Target at $110 on, Jun 15th, 2021.
Yun has made no other calls on SRPT in the last 4 months.
There are 4 other peers that have a rating on SRPT. Out of the 4 peers that are also analyzing SRPT, 1 agrees with Yun's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $93 on, Monday, April 19th, 2021
These are the ratings of the 3 analyists that currently disagree with Yun
- Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $126 on, Tuesday, March 2nd, 2021
- Difei Yang of "Mizuho" Maintained at Strong Buy with Increased Target to $160 on, Friday, February 26th, 2021
- Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy and Held Target at $135 on, Friday, February 26th, 2021